free counters

Placenta Protein May Lead to Rheumatoid Arthritis Treatment

Researchers are not sure of the exact causes of rheumatoid arthritis (RA), but they have discovered that cytokines (bioactive proteins), in particular TNF-alpha and IL-6 are significant contributors. These cytokines cause inflammation which leads to destruction of the joints and tissues.

The action of another cytokine, placenta growth factor (PIGF), is suspected to be critical for the formation of new blood vessels in the placenta necessary to deliver adequate oxygen and nutrients to fetus. A new study led by Wan-Uk Kim of Catholic University of Korea in Seoul, Korea, examined the impacts of PIGF on the inflammatory process of RA. The results of the study suggest that PIGF may have an important role in inflammation in joints with rheumatoid arthritis.

The researchers analyzed blood and synovial fluid cells from RA patients and from healthy controls. They discovered that the key source of PIGF production in RA patients is the synovial cells and that PIGF stimulates TNF-alpha and IL-6 production. They also found that the increases in TNF-alpha and IL-6 production induced by PIGF might be caused by high levels of a PIGF receptor, know as flt-1, which is linked to the inflammatory response of RA patients. Additionally, the researchers identified a new peptide to inhibit PIGF action. Injecting this peptide into arthritic mice resulted in reduced severity of arthritis and prevention of the arthritis progression. They also determined that eliminating the PIGF gene in mice prevented the development of antibody-induced arthritis.

The peptide they identified inhibits binding of PIGF to the flt-1 receptor and could be clinically valuable because it is easily synthesized and does not elicit unwanted immune response.

According to the report authors, “These findings provide new insight into the pathogenic mechanism of RA and emphasize the importance of PIGF and flt-1 as potential candidates for therapy, in addition to their being a common cue of angiogenesis and the inflammatory process.”

The researchers are currently conducting research to improve the activity of the anti-flt-1 peptide by modifying its length and structure.

GD Star Rating
loading...

Originally posted 2009-03-06 06:43:53. Republished by Blog Post Promoter

Related posts:

  1. Rheumatoid Arthritis Treatment Improves Dementia
  2. Suicide Cell Developed to Treat Rheumatoid Arhtritis
  3. Rheumatoid Arthritis: Anti-TNF vs. DMARDS

2 comments to Placenta Protein May Lead to Rheumatoid Arthritis Treatment

  • Christielea

    I really enjoy Current Arthritis News And Research-great material and excellent writing.

    I’d like to invite you to check out Joints Like Mine (www.jointslikemine.com)-Canada’s online community dedicated to those living with joint pain.

    Not only is it a place for people to share their stories, it’s a one-stop information portal where members learn the latest research developments that will give them success on their road to recovery.

    We’re currently gathering links to health and fitness websites that will give Joints Like Mine members all the information they need.

    If you have any great links to share, please pass them along-we’ll post them on Joints Like Mine.

    All the best,

    Christie Adams
    Community Manager
    Joints Like Mine

    GD Star Rating
    loading...
  • my grandmother also suffers from arthritis. she just takes glucosamine, chondroitin and lots of vitamin-c as supplemental therapy for arthritis.

    GD Star Rating
    loading...

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Click to hear an audio file of the anti-spam word

Related from Amazon

Archives